DPTX-3186

N/A

Report date: 2026/01/07 20:01:01
NME

Base Information

Drug NameDPTX-3186
Drug Alias NameDPTX3186DPTX-3186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 inhibitors
TargetsCatenin beta 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDewpoint Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDewpoint Therapeutics IncConcertAI LLC
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A